AVANOS MEDICAL, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Avanos Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q2 2024.
  • Avanos Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.8M.
  • Avanos Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $7.7M.
  • Avanos Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$61.8M, a 222% decline from 2022.
  • Avanos Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $50.5M, a 702% increase from 2021.
  • Avanos Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $6.3M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.7M $1.8M +$69.9M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 -$62.2M -$900K -$400K -80% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$61.8M $10.5M -$6.4M -37.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$55.4M -$3.7M -$19.4M -124% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$36M -$68.1M -$80.6M -645% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $44.6M -$500K -$5.9M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $50.5M $16.9M +$5.4M +47% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $45.1M $15.7M +$51M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$5.9M $12.5M -$26M -67.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $20.1M $5.4M +$13.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $6.3M $11.5M +$60.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$54.2M -$35.3M -$54.6M -283% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $400K $38.5M +$41.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$41.1M -$8.4M -$12.1M -327% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$29M -$49M -$42.9M -703% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $13.9M $19.3M +$30.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$16.9M -$3M +$5M +62.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$21.9M $3.7M +$24M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$45.9M -$6.1M -$3.9M -177% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$42M -$11.5M -$15.7M -374% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$26.3M -$8M -$43.3M -123% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $17M -$20.3M -$40.5M -200% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $57.5M -$2.2M -$35M -107% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $92.5M $4.2M -$12.4M -74.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $105M $35.3M +$18.2M +106% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $86.7M $20.2M +$7.4M +57.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $79.3M $32.8M +$22.8M +228% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $56.5M $16.6M +$7.5M +82.4% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 $49M $17.1M +$10.6M +163% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $38.4M $12.8M -$1.4M -9.86% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $39.8M $10M -$4.5M -31% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $44.3M $9.1M +$480M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$435M $6.5M -$1.5M -18.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$434M $14.2M -$7.5M -34.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$426M $14.5M +$16.9M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$443M -$471M -$463M -6258% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $19.9M $8M +$12.5M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $7.4M $21.7M -$19.7M -47.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $27.1M -$2.4M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$7.4M -$55.3M -115% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$4.5M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $41.4M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $47.9M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.